Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · IEX Real-Time Price · USD

0.938

+0.056 (6.35%)

At close: Apr 18, 2024, 4:00 PM

0.920

-0.018 (-1.92%)

After-hours: Apr 18, 2024, 6:01 PM EDT

Enveric Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013
Revenue	0	0	0	0	0	43	48.59	36.15	20.26	6.14
Revenue Growth (YoY)	-	-	-	-	-	-11.51%	34.44%	78.40%	229.75%	-
Cost of Revenue	0	0	0	0	0	34.01	38.36	29.22	13.39	5.23
Gross Profit	0	0	0	0	0	8.98	10.24	6.93	6.87	0.91
Selling, General & Admin	8.85	11.61	20.5	5.32	2.3	10.79	18.51	9.36	5.84	0.28
Research & Development	7.25	8.03	4.79	0.17	0	0	0	0	0	0
Other Operating Expenses	0.34	7.78	39.34	0.12	0	5.34	2.62	2.95	1.82	0
Operating Expenses	16.45	27.42	64.62	5.62	2.3	16.13	21.13	12.31	7.66	0.28
Operating Income	-16.45	-27.42	-64.62	-5.62	-2.3	-7.15	-10.9	-5.38	-0.79	0.63
Interest Expense / Income	-0	0.01	0.01	0.45	0.08	0.73	0.58	0.75	0.24	0
Other Expense / Income	0.82	-7.46	-8.2	0.8	0.03	2.67	-0	0.4	-0.09	-0
Pretax Income	-17.26	-19.96	-56.43	-6.86	-2.41	-10.55	-11.47	-6.53	-0.94	0.63
Income Tax	0.03	-1.49	-7.45	0	0	6.35	-2.39	-3.75	-0.13	0.21
Net Income	-17.29	-18.47	-48.98	-6.86	-2.41	-16.9	-9.07	-2.78	-0.81	0.41
Preferred Dividends	0.17	0.33	0	0	0	2.58	2.09	0	0	0
Net Income Common	-17.46	-18.8	-48.98	-6.86	-2.41	-19.48	-11.16	-2.78	-0.81	0.41
Shares Outstanding (Basic)	2	1	0	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	2	1	0	0	0	0	0	0	0	0
Shares Change	49.31%	206.13%	310.48%	8.82%	2122.43%	58.76%	14.65%	17.75%	16976.92%	-
EPS (Basic)	-8.09	-13.00	-103.69	-59.50	-23.00	-4094.00	-3750.00	-1050.00	-350.00	31650.00
EPS (Diluted)	-8.09	-13.00	-103.69	-59.50	-23.00	-4094.00	-3750.00	-1050.00	-350.00	31650.00
Free Cash Flow	-14.08	-17.73	-11.65	-3.89	-0.65	-2.56	-2.75	-2.73	-1.07	-
Free Cash Flow Per Share	-6.52	-12.26	-24.66	-33.79	-6.13	-537.85	-916.26	-1045.66	-481.46	-
Gross Margin	-	-	-	-	-	20.89%	21.07%	19.17%	33.91%	14.83%
Operating Margin	-	-	-	-	-	-16.62%	-22.42%	-14.88%	-3.92%	10.22%
Profit Margin	-	-	-	-	-	-45.31%	-22.97%	-7.69%	-4.02%	6.75%
Free Cash Flow Margin	-	-	-	-	-	-5.95%	-5.65%	-7.56%	-5.28%	-
Effective Tax Rate	-	-	-	-	-	-	-	-	-	34.00%
EBITDA	-16.86	-19.52	-55.74	-6.3	-2.33	-6.92	-7.67	-4.42	-0.54	-
EBITDA Margin	-	-	-	-	-	-16.08%	-15.79%	-12.22%	-2.65%	-
Depreciation & Amortization	0.41	0.44	0.68	0.12	0	2.9	3.22	1.36	0.17	-
EBIT	-17.27	-19.95	-56.42	-6.42	-2.33	-9.82	-10.89	-5.78	-0.7	0.63
EBIT Margin	-	-	-	-	-	-22.84%	-22.41%	-15.98%	-3.47%	10.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).